Journals / Erciyes Medical Journal / 2020 / Cilt: 42 - Sayı: 2

An Atypical Case with Chronic Granulomatous Disease and Kabuki Syndrome

Pages
229–232
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CGD is always considered for the differential diagnosis during BCGitis history and recurrent skin abscess.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic granulomatous disease (CGD) is a rare inherited immunodeficiency that arises from defects in the NADPH oxidase complex, primarily affecting the respiratory burst in neutrophils.
📊
Key Findings & Data:A 20-year-old male was admitted with the complaints of the recurrent abscess.
💡
Conclusion & Impact:CGD is always considered for the differential diagnosis during BCGitis history and recurrent skin abscess.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Chronic granulomatous disease (CGD) is a rare inherited immunodeficiency that arises from defects in the NADPH oxidase complex, primarily affecting the respiratory burst in neutrophils. Kabuki syndrome (KS) is a rare genetic syndrome and often present with facial, skeletal, visceral and cardiac anomalies, immunological defects and varying degrees of mental retardation. A 20-year-old male was admitted with the complaints of the recurrent abscess. He had a history of recurrent abscesses and long-term antituberculosis treatment. Cytometric functional analysis, Sanger sequencing and whole-exome sequencing were used for the diagnosis of CGD. Both AR-CGD (p67phox defect) with homozygous c.229C>T nonsense mutation in NCF2 gene and heterozygous nucleotide change c.3983G>A in the KMT2D gene causing a novel missense mutation p. Arg1328Gln resulted in Kabuki syndrome. To our knowledge, this is the first report of both CGD and Kabuki syndrome combined in a single patient. CGD is always considered for the differential diagnosis during BCGitis history and recurrent skin abscess.

🔖

Cite This Article

KÖKER, M. Y., TÜRE, Z., KÖKER, N., METAN, G. (2020). An Atypical Case with Chronic Granulomatous Disease and Kabuki Syndrome. Erciyes Medical Journal, Cilt: 42 - Sayı: 2, 229–232. https://ajindex.com/articles/158700

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol 2013; 132(5): 1156–63.e5
  2. Miyake N, Koshimizu E, Okamoto N, Mizuno S, Ogata T, Nagai T, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet A 2013; 161A(9): 2234–43
  3. Ciprero KL, Clayton-Smith J, Donnai D, Zimmerman RA, Zackai EH, Ming JE. Symptomatic Chiari I malformation in Kabuki syndrome. Am J Med Genet A 2005; 132A(3): 273–5
  4. Köker MY, Sanal O, van Leeuwen K, de Boer M, Metin A, Patiroğlu T, et al. Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations. Eur J Clin Invest 2009; 39(10): 942–51
  5. Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol 2007; 120(1): 32–8
  6. Fruergaard S, Ohrt-Nissen S, Dahl B, Kaltoft N, Gehrchen M. Neural Axis Abnormalities in Patients With Adolescent Idiopathic Scoliosis: Is Routine Magnetic Resonance Imaging Indicated Irrespective of Curve Severity?. Neurospine 2019; 16(2): 339–46
  7. Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, et al. T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nat Commun 2016; 7: 11290
  8. Garly ML, Martins CL, Balé C, Baldé MA, Hedegaard KL, Gustafson P, et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 2003; 21(21-22): 2782–90
  9. Lin JL, Lee WI, Huang JL, Chen PK, Chan KC, Lo LJ, et al. Immunologic assessment and KMT2D mutation detection in Kabuki syndrome. Clin Genet 2015; 88(3): 255–60
  10. Uribe-Querol E, Rosales C. Control of Phagocytosis by Microbial Pathogens. Front Immunol 2017; 8: 1368
  11. Lindsley AW, Saal HM, Burrow TA, Hopkin RJ, Shchelochkov O, Khandelwal P, et al. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome. J Allergy Clin Immunol 2016; 137(1): 179–87.e10.